~ Frederick Douglass
Book your appointment now!By: Joann Amoroso RDH MAS™ QOM®
The American Academy of Pediatric Dentistry (AAPD) has made a significant shift in how it approaches the developing dentition and occlusion, recognizing the critical role of airway health, oral habits, and myofunctional therapy in pediatric dental care. This marks a pivotal change in how we assess and treat children’s dental and facial development, moving beyond just straight teeth to a more comprehensive approach that prioritizes function, growth, and long-term health.... read more
Feb
By: Joann Amoroso-Pernice RDH, MAS™, QOM®
In a landmark move, the U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide) as the first-ever medication specifically for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults who also suffer from obesity. Manufactured by Eli Lilly, this approval marks a new era in OSA treatment, especially for patients who are unable to tolerate or adhere to traditional therapies like CPAP (Continuous Positive Airway Pressure). However, while this drug offers promising results, its side effects and potential risks mean that it may not be the right choice for everyone.... read more
Dec
By: CAFF Team
Are your children snoring, awakening with dry mouth and headaches, and having trouble staying awake and focused during the day?... read more
Oct